Bioextrax AB (OSTO:BIOEX) NonCurrent Deferred Liabilities: kr0.00 Mil (As of Mar. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Bioextrax AB OSTO:BIOEX

64 GF Score

Price kr2.03

GF Value kr1.84

Valuation Fairly Valued

4 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Bioextrax AB NonCurrent Deferred Liabilities?

Bioextrax AB OSTO:BIOEX +0.50% 64 NonCurrent Deferred Liabilities is kr0.00 Mil as of Mar. 2026. GuruFocus rates OSTO:BIOEX with a GF Score™ of 64/100 and a GF Value™ of kr1.84 (Fairly Valued). The stock has 4 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Bioextrax AB's non-current deferred liabilities for the quarter that ended in Mar. 2026 was kr0.00 Mil.

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Bioextrax AB NonCurrent Deferred Liabilities Related Terms

Bioextrax AB NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Bioextrax AB's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioextrax AB NonCurrent Deferred Liabilities Chart

Bioextrax AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

NonCurrent Deferred Liabilities

Get a 7-Day Free Trial

0.00

Bioextrax AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
NonCurrent Deferred Liabilities	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

64GF Score

Bioextrax AB OSTO:BIOEX

NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Frequently Asked Questions Learn more about NonCurrent Deferred Liabilities →

What does a NonCurrent Deferred Liabilities of kr0.00 Mil mean?

Bioextrax AB (OSTO:BIOEX) has a NonCurrent Deferred Liabilities of kr0.00 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Bioextrax AB and its competitors.

Is Bioextrax AB's NonCurrent Deferred Liabilities too high?

Bioextrax AB's current NonCurrent Deferred Liabilities is kr0.00 Mil. Overall, Bioextrax AB has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Bioextrax AB's NonCurrent Deferred Liabilities compare to WM and RSG?

Bioextrax AB's NonCurrent Deferred Liabilities of kr0.00 Mil can be compared against companies in the Waste Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good NonCurrent Deferred Liabilities for a Waste Management company?

A good NonCurrent Deferred Liabilities depends on the Waste Management industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high NonCurrent Deferred Liabilities mean?

A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Bioextrax AB and its competitors. Bioextrax AB's current NonCurrent Deferred Liabilities is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bioextrax AB stock overvalued right now?

Based on GuruFocus' analysis, Bioextrax AB (OSTO:BIOEX) is currently considered Fairly Valued. The stock's GF Value™ is kr1.84, compared to a current price of kr2.03 — trading 10.3% above its estimated fair value. The current NonCurrent Deferred Liabilities is kr0.00 Mil. Bioextrax AB's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is NonCurrent Deferred Liabilities calculated?

NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Bioextrax AB (OSTO:BIOEX), the current NonCurrent Deferred Liabilities is kr0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioextrax AB (OSTO:BIOEX) Overvalued in 2026?

Based on GuruFocus' analysis, Bioextrax AB stock appears to be overvalued. The current stock price of kr2.03 is trading 10.3% above its estimated GF Value™ of kr1.84. GuruFocus considers Bioextrax AB to be Fairly Valued.

Key valuation signals for OSTO:BIOEX:

NonCurrent Deferred Liabilities: kr0.00 Mil
GF Value™: kr1.84 vs. price of kr2.03 (10.3% above fair value)
GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the OSTO:BIOEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →